|
[1]Willatt JM, Hussain HK, Adusumilli S, et al.MR imaging of hepato-cellular carcinoma in the cirrhotic liver:challenges and controversie[J].Radiology, 2008, 247 (2) :311-330.
|
|
[2]Hanna RF, Aguirre DA, Kased N, et al.Cirrhosis-associated hepa-tocellular nodules:correlation of histopathologic and MR Imaging fea-tures[J].RadioGraphics, 2008, 28 (3) :747-769.
|
|
[3]Hussain SM, Zondervan PE, Ijzermans JNM, et al.Benign versus malignant hepatic nodules:MR imaging findings with pathologic cor-relation[J].Radiographics, 2002, 22 (5) :1023-1036.
|
|
[4]Hussain HK, Syed I, Nghiem HV, et al.T2-weighted MR imaging in the assessment of cirrhotic liver[J].Radiology, 2004, 230 (3) :637-644.
|
|
[5]Hecht E, Hollanf AE, Israel GM, et al.Hepatocellular carcinoma in the cirrhotic Liver:gadolinium-enhanced3D T1-weighted MR im-aging as a stand-alone sequence for diagnosis[J].Radiology, 2006, 239 (2) :438-447.
|
|
[6]Ito K, Fujita T, Shimizu1A, et al.Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepati-tis:differentiating between hypervascular hepatocellular carcinomasand pseudolesions[J].AJR, 2004, 183 (3) :699-705.
|
|
[7]Gandhi SN, Brown MA, Wong JG, et al.MR contrast agents for liver imaging:what, when, how[J].Radio Graphics2006, 26 (6) :1621-1636.
|
|
[8]Halavaara J, Breuer J, Ayuso G, et al.Liver tumor characterization:comparison between liver-specific gadoxetic acid disodium-en-hanced MRI and biphasic CT-a multicenter trial[J].J Comput As-sist Tomogr, 2006, 30 (3) :345-354.
|
|
[9]Kim YK, Kim CS, Lee YH, et al.Comparison of superparamagnetic i-ron oxide-enhanced and gadobenate dimeglumine-enhanced dy-namic MRI for detection of small hepatocellular carcinomas[J].AJR, 2004, 182 (6) :1217-1223.
|
|
[10]Jeong YY, Yim NY, Kang HK.Hepatocellular carcinoma in the cir-rhotic liver with helical CTand MRI:imaging spectrumand pitfalls of cirrhosis-related nodules[J].AJR, 2005, 185 (4) :1024-1032.
|
|
[11]Richard LB, Mark S P.Screening the cirrhotic liver for hepatocellu-lar carcinoma with CT and MR imaging:opportunities and pitfalls[J].Radiographics, 2001, 21 (s) :S117-S132.
|
|
[12]Krinsky GA, Lee VS, Theise ND, et al.Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis:prospective diagno-sis with MR imaging and explantation correlation[J].Radiology, 2001, 219 (2) :445-454.
|
|
[13]Yu JS, Chung JJ, KimJH, et al.Fat-containing nodules in the cir-rhotic liver:chemical shift MRI features and clinical implications[J].AJR, 2007, 188 (4) :1009-1016.
|
|
[14]Lutz AM, Willmann JK, Goepfert K, et al.Hepatocellular carcinoma in cirrhosis:enhancement patterns at dynamic gadolinium-and su-perparamagnetic iron oxide-enhanced T1-weighted MR i maging[J].Radiology, 2005, 237 (2) :520-528.
|
|
[15]Ishigami K, Yoshimitsu K, Nishihara Y, et al.Hepatocellular carci-noma with a pseudocapsule on Gadolinium-enhanced MR Images:correlation with histopathologic findings[J].Radiology, 2009, 250 (2) :435-443.
|
|
[16]Krinsky GA, Israel G.Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR Imaging:frequency in cirrhotic patients undergoing transplantation[J].AJR, 2003, 180 (4) :1023-1027.
|
|
[17]Hwang SH, Yu JS, Kin KW, et al.Small hypervascular enhancing le-sions on arterial phase images of multiphase dynamic computed tomo-graphy in cirrhotic liver:fate and implications[J].J Comput Assist Tomogr, 2008, 32 (1) :39-45.
|
|
[18]Holland AE, Hecht EM, Hahn WY, et al.Importance of Small (20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver:evaluation and comparison with whole explanted liver[J].Radiology, 2005, 237 (4) :938-944.
|
|
[19]Shinmura R, Matsui O, Kobayashi S, et al.Cirrhotic nodules:asso-ciation between MR imaging signal intensity and intranodular blood supply[J].Radiology, 2005, 237 (2) :512-519.
|
|
[20]Carlos RC, Kim HM, Hussain HK, et al.Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis[J].AJR, 2003, 180 (3) :893-900.
|
PDF下载 ( 117 KB)
本文二维码
下载:
